Global Point Of Care Hematology Diagnostics Market Set for Strong Expansion Reaching $4.39 Billion by 2030 at 8.6% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Point Of Care Hematology Diagnostics Market Projected To Become By 2030 Based On Its 2026 Valuation?
The market size for point of care hematology diagnostics has demonstrated robust growth in recent years. Forecasts indicate it will expand from $2.9 billion in 2025 to $3.16 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. The expansion observed in the historic period is attributable to several factors, including a reliance on centralized laboratory testing, the escalating burden of anemia and blood disorders, an uptick in hospital emergency admissions, the imperative for faster diagnostic turnaround, and restricted access to laboratory infrastructure in rural areas.
The point of care hematology diagnostics market size is projected for substantial expansion in the coming years, with expectations to reach $4.39 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth is driven by factors such as the increasing prevalence of chronic and infectious diseases, the expansion of point of care testing initiatives, a heightened need for rapid diagnostic solutions in emergency medical situations, ongoing technological progress in compact hematology analyzers, and the development of decentralized healthcare delivery systems. Key trends influencing the market during this period involve the growing adoption of quick bedside blood testing, a rising demand for decentralized diagnostics, particularly in urgent care environments, the increasing utilization of portable and handheld hematology devices, the spread of point of care testing into areas with limited resources, and an emphasis on achieving faster turnaround times for critical clinical decisions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp
What Drivers Are Shaping The Future Growth Of The Point Of Care Hematology Diagnostics Market?
The growing prevalence of blood conditions is anticipated to propel the expansion of the point-of-care hematology diagnostics market moving forward. Blood disorders are defined as ailments that affect the components of blood, including red blood cells, white blood cells, platelets, or plasma. The increasing incidence of these disorders primarily results from the rising occurrence of chronic diseases, which directly impact blood health and require continuous monitoring. Point-of-care hematology diagnostics assist in the timely identification and tracking of blood disorders by providing rapid, accurate results at or near the patient’s care site, thus enabling quicker clinical decisions and improved disease management. For instance, in November 2024, The American Society of Hematology, a US-based Non-profit organization, projected that global leukemia cases could increase to approximately 519,540 by 2050. Therefore, the escalating incidence of blood disorders is driving the growth of the point-of-care hematology diagnostics market.
What Segment Groups Are Identified Within The Point Of Care Hematology Diagnostics Market?
The point of care hematology diagnostics market covered in this report is segmented –
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
3) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing
What Trends Are Advancing Progress In The Point Of Care Hematology Diagnostics Market?
Companies operating significantly within the point-of-care hematology diagnostics market are concentrating on developing advanced products, such as cartridge-based AI-powered hematology analyzers. Their goal is to provide swift, precise, and on-site blood analysis to enhance patient care. These cartridge-based AI-powered hematology analyzers are compact diagnostic instruments that employ single-use reagent cartridges and artificial intelligence algorithms to quickly and accurately analyze blood samples directly at the point of care. For example, in September 2024, Zoetis Inc., a US-based veterinary health company, introduced Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer developed for veterinary applications. This innovative system delivers rapid, reference laboratory-quality complete blood count (CBC) results in mere minutes at the point of care, while also decreasing maintenance and hands-on time. It incorporates advanced AI-driven image analysis and viscoelastic focusing technology to precisely align cells for clear imaging, thereby enabling accurate blood cell classification and automated abnormality detection, which ensures efficient and reliable veterinary diagnostics.
Which Companies Hold Significant Positions In The Point Of Care Hematology Diagnostics Market?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., BioMedomics Inc., PixCell Medical Technologies Ltd., Boule Diagnostics AB, Nihon Kohden Corporation, Edan Instruments Inc., A Menarini Industrie Farmaceutiche Srl, Becton Dickinson and Company, Ortho Clinical Diagnostics, Khema Diagnostics, Bio-Rad Laboratories Inc.
Read the full point of care hematology diagnostics market report here:
Which Geographic Regions Are Influencing Demand In The Point Of Care Hematology Diagnostics Market?
North America was the largest region in the point of care hematology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Point Of Care Hematology Diagnostics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp
Browse Through More Reports Similar to the Global Point Of Care Hematology Diagnostics Market 2026, By The Business Research Company
Architectural And Structural Metals Market Report 2026
Architectural And Structural Metals Market Report 2026
Buildings Construction Market Report 2026
https://www.thebusinessresearchcompany.com/report/buildings-construction-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
